- Advanced or metastatic non-small lung cancer (NSCLC)
- Advanced or metastatic pancreatic cancer

ERLOCIP 100MG
| MRP | : |
|
| Price | : | ₹3,550.00 |
| You Save | : | ₹2,595.15 (42.23%) |
30 Tablet(s) In A Bottle
Erlocip 100mg Tablet is a medication used to combat cancer. Cancer is characterized by the abnormal and uncontrolled growth of cells in the body. This tablet is specifically utilized for treating patients with advanced or metastatic non-small cell lung cancer.
Erlocip 100mg Tablet is administered alongside Gemcitabine for the treatment of metastatic pancreatic cancer. The use of this medication may result in kidney and liver failure, thus doctors will regularly check kidney and liver functions. It is important to inform the physician of any history related to clotting disorders or any medications taken for such conditions, as Erlocip 100mg Tablet may heighten the risk of bleeding.
Patients should notify their doctor if they experience eye pain, blurred vision, cough, fever, shortness of breath, severe abdominal pain, or persistent diarrhea while on this medication. Additionally, patients are advised against smoking during treatment, as it may reduce the effectiveness of the medication in the bloodstream. It is also recommended to wear protective clothing and apply sunscreen when outdoors.